Large gap with delayed quotes
|
Last quote
07/03/2025
-
23:00:00
|
Bid
07/03/2025 -
18:59:59
|
Bid Volume |
Ask
07/03/2025 -
18:59:59
|
Ask Volume |
|---|---|---|---|---|
|
11.12
+0.06
(
+0.54% )
|
11.11
|
3,300 |
11.14
|
1,100 |
Analysis date: 01.07.2025
Global Evaluation
Negativ
Negativ
The stock is classified in the negative zone since 24.06.2025.
Interest
None
None
No stars since 24.06.2025.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 24.06.2025 at a price of 10.97.
Evaluation
Strongly overvalued
Strongly overvalued
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
Negative
Negative
The forty day technical trend is negative since 21.02.2025.
4wk Rel Perf
-1.28%
-1.28%
The four-week dividend-adjusted underperformance versus SP500 is 1.28%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 11.02.2025.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.03%.
Mkt Cap in $bn
0.44
0.44
With a market capitalization <$2bn, ORTHOFIX MEDICAL is considered a small-cap stock.
G/PE Ratio
0.76
0.76
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
-14.13
-14.13
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
10.77%
10.77%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
3
3
Over the last seven weeks, an average of 3 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
79
79
For 1% of index variation, the stock varies on average by 0.79%.
Correlation
0.40
0.40
Stock movements are strongly independent of index variations.
Value at Risk
2.68
2.68
The value at risk is estimated at USD 2.68. The risk is therefore 24.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
11.07.2008
11.07.2008